Skip to content

TECHNIQUE OF SENTINAL LYMPHNODE BIOPSY IN BREAST CANCER

Standardization of Sentinel Lymphnode Biopsy Technique For Breast Cancer and route map for sentinel node detection - SLNB STUDY

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/02/006592
Enrollment
70
Registered
2016-02-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- BREAST CANCER PATIENTS

Interventions

Intervention1: INJECTION OF METHYLENE BLUE INTO BREAST: IDENTIFY THE BEST SITE OF INJECTION AND LOCATION OF SENTINAL NODE Intervention2: PERITUMOURAL INJECTION: 3ML OF DYE INJECTED INTO BREAST VARIOUS

Sponsors

PRINCIPLE INVESTIGATOR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i. Breast cancer Patient coming to surgical oncology department of st johns medical college ii. Node negative iii. Mammography detected nodes who are negative in FNAC iv. Undergoing MRM and BCS

Exclusion criteria

Exclusion criteria: i. Node positive ii. Pregnant women and lactating women iii. Neoadjuvant treated patients iv. Previous breast surgery v. Metastatic breast cancer vi. Previous history of radiation to breast or axilla vii. Previous axillary surgery patients

Design outcomes

Primary

MeasureTime frame
â?¢ Standardize the site of methylene blue injection for breast sentinel lymphnode biopsy â?¢ Timepoint: ONE AND HALF YEARS

Secondary

MeasureTime frame
â?¢ Find out the most common relations of sentinel node to various structure in axilla. Timepoint: ONE AND HALF YEARS

Countries

India

Contacts

Public ContactDr Suraj Manjunath

St. Johnâ??s Medical College Hospital

reachsuraj@rediffmail.com08022065907

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026